Rosetta Capital (UK) Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 5

Professionals

  • Investments
  • 69

  • Portfolio
  • 12

  • Exits
  • 56

Exits

Rosetta Capital (UK) General Information

Company Description

Founded in 2001, Rosetta Capital is a venture capital firm based in Haddenham, United Kingdom. The firm prefers to invest through direct secondary transactions in companies operating in the life science, healthcare, medical devices, and medical technology sectors. The firm prefers to invest in Europe, North America, and Asia.

Business Details

Website
www.rosettacapital.com
Year Founded
2001
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Secondary Buyer
Corporate Office
  • Rectory House
  • Haddenham HP17 8DA
  • England, United Kingdom
+44 01844

Rosetta Capital (UK) Investments (69)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Mission Therapeutics 11-Mar-2024 Later Stage VC Drug Discovery Clinical Trials - Phase 2
JenaValve Technology 01-Mar-2023 Therapeutic Devices Generating Revenue
Carrick Therapeutics 03-Mar-2022 Drug Discovery Clinical Trials - Phase 2
Carrick Therapeutics 15-Mar-2021 Drug Discovery Clinical Trials - Phase 2
Inivata 15-Mar-2021 Diagnostic Equipment Generating Revenue
Mereo Biopharma 15-Mar-2021 Drug Discovery Generating Revenue
ReNeuron Group 15-Mar-2021 Drug Discovery Bankruptcy: Admin/Reorg
Oxular 01-Mar-2021 Drug Discovery Clinical Trials - Phase 2
Akamis Bio 27-Jan-2021 Secondary Transaction - Private Drug Discovery Clinical Trials - Phase 1
Mission Therapeutics 27-Jan-2021 Secondary Transaction - Private Drug Discovery Clinical Trials - Phase 2
You’re viewing 10 of 69 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rosetta Capital (UK) Exits (56)

Company Name Exit Date Exit Type Exit Size
Oxular 02-Jan-2025 Merger/Acquisition
Mereo Biopharma 14-Jun-2024
ReNeuron Group 20-Mar-2024
Promore Pharma 29-Dec-2023
Librestream 01-Sep-2023
EyeSense 01-Nov-2022
Clanotech 02-Jun-2022
Promimic 29-Apr-2022
Axelar (Drug Discovery) 22-Oct-2021 Out of Business
Tepha 27-Jul-2021 Merger/Acquisition
You’re viewing 10 of 56 exits. Get the full list »

Rosetta Capital (UK) Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Rosetta Capital (UK)‘s full profile, request access.

Request a free trial

Rosetta Capital (UK) Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Rosetta Capital (UK) Co-Investors (14)

Name With Exits Lead Partner Series Industry
IP Group 2 Series chart Industry bar
ARCH Venture Partners Series chart Industry bar
Forbion Series chart Industry bar
NeoMed Management Series chart Industry bar
Roche Venture Fund Series chart Industry bar
You’re viewing 5 of 14 co-investors. Get the full list »

Rosetta Capital (UK) Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Clanotech Solna, Sweden 2005

Rosetta Capital (UK) FAQs

  • What is Rosetta Capital (UK)?

    Founded in 2001, Rosetta Capital is a venture capital firm based in Haddenham, United Kingdom.

  • When was Rosetta Capital (UK) founded?

    Rosetta Capital (UK) was founded in 2001.

  • Where is Rosetta Capital (UK) headquartered?

    Rosetta Capital (UK) is headquartered in Haddenham, United Kingdom.

  • How many investments has Rosetta Capital (UK) made?

    Rosetta Capital (UK) has made 69 investments.

  • What has Rosetta Capital (UK) invested in?

    Rosetta Capital (UK) has made numerous investments in companies like Mission Therapeutics, JenaValve Technology, and Carrick Therapeutics within the Drug Discovery and Therapeutic Devices industries.

  • What has Rosetta Capital (UK) invested in recently?

    Rosetta Capital (UK)'s latest investment was on 11-Mar-2024 in Mission Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »